TrialCancer medicine2020

Efficacy of NEPA, a fixed antiemetic combination of netupitant and palonosetron, vs a 3-day aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients receiving highly emetogenic chemotherapy (HEC) in a randomized Phase 3 study.

Jianhua Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.